PNC Financial Services Group
XENE icon

PNC Financial Services Group’s Xenon Pharmaceuticals XENE Stock Holding History

PNC Financial Services Group’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Buy
8,701
+604
+7% +$33.5K ﹤0.01% 1754
2026
Q1 		$471K Buy
8,097
+1,523
+23% +$70.2K ﹤0.01% 1724
2025
Q4 		$295K Buy
6,574
+675
+11% +$28.3K ﹤0.01% 2022
2025
Q3 		$237K Buy
5,899
+2,437
+70% +$85.8K ﹤0.01% 2181
2025
Q2 		$108K Sell
3,462
-1,758
-34% -$57.3K ﹤0.01% 2656
2025
Q1 		$175K Buy
5,220
+80
+2% +$3.04K ﹤0.01% 2276
2024
Q4 		$201K Buy
5,140
+180
+4% +$7.44K ﹤0.01% 2208
2024
Q3 		$195K Buy
4,960
+120
+2% +$4.84K ﹤0.01% 2199
2024
Q2 		$189K Buy
4,840
+2,160
+81% +$86.3K ﹤0.01% 2189
2024
Q1 		$115K Buy
2,680
+700
+35% +$32.2K ﹤0.01% 2528
2023
Q4 		$91.2K Buy
+1,980
New +$70K ﹤0.01% 2677
2021
Q3 		– Sell
-45,722
Closed -$851K – 4420
2021
Q2 		$851K Hold
45,722
– – ﹤0.01% 1281
2021
Q1 		$818K Hold
45,722
– – ﹤0.01% 1262
2020
Q4 		$703K Hold
45,722
– – ﹤0.01% 1291
2020
Q3 		$506K Hold
45,722
– – ﹤0.01% 1354
2020
Q2 		$573K Hold
45,722
– – ﹤0.01% 1296
2020
Q1 		$518K Hold
45,722
– – ﹤0.01% 1267
2019
Q4 		$599K Hold
45,722
– – ﹤0.01% 1373
2019
Q3 		$412K Hold
45,722
– – ﹤0.01% 1700
2019
Q2 		$451K Buy
45,722
+34,022
+291% +$326K ﹤0.01% 1681
2019
Q1 		$119K Buy
+11,700
New +$99.2K ﹤0.01% 2455

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PNC Financial Services Group's XENE Position: Q2 2026 in Review

PNC Financial Services Group increased its Xenon Pharmaceuticals (XENE) stake by 7.5% in Q2 2026, buying an estimated $33.5K and bringing the position to 8,701 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

PNC Financial Services Group first reported a position in XENE in Q1 2019 and has held it in 21 quarters since. The position peaked at $851K in Q2 2021. 148 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • PNC Financial Services Group held 8,701 shares of Xenon Pharmaceuticals worth $525K as of Q2 2026.
  • PNC Financial Services Group bought 604 Xenon Pharmaceuticals shares in Q2 2026, an estimated $33.5K.
  • Xenon Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1754 holding.
  • PNC Financial Services Group first reported a position in Xenon Pharmaceuticals in Q1 2019 and has held it in 21 quarters since.
  • PNC Financial Services Group's Xenon Pharmaceuticals position peaked at $851K in Q2 2021.
  • 148 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.